loading page

Association of UGT1A1*6,*28 or ABCC2 c.3972C>T genetic polymorphisms with irinotecan induced toxicity in Asian cancer patients: Meta-analysis
  • +6
  • Chalirmporn Atasilp,
  • Mohitosh Biswas,
  • Pimonpan Jinda,
  • Nutthan Nuntharadthanaphong,
  • Jiratha Rachanakul,
  • Yaowaluck Hongkaew,
  • Natchaya Vanwong,
  • Surasak Saokaew,
  • Chonlaphat Sukasem
Chalirmporn Atasilp

Corresponding Author:[email protected]

Author Profile
Mohitosh Biswas
University of Rajshahi
Author Profile
Pimonpan Jinda
Author Profile
Nutthan Nuntharadthanaphong
Author Profile
Jiratha Rachanakul
Author Profile
Yaowaluck Hongkaew
Author Profile
Natchaya Vanwong
Author Profile
Surasak Saokaew
Author Profile
Chonlaphat Sukasem
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Author Profile


Abstract: Background: Effects of UGT1A1*6 and UGT1A1*28 genetic polymorphisms on irinotecan-induced severe toxicities in Asian cancer patients are inconclusive. Also, ABCC2 c.3972C>T may affect toxicity of irinotecan. It was aimed to assess the aggregated risk of neutropenia or diarrhea in Asian cancer patients taking irinotecan and inherited UGT1A1*6, UGT1A1*28 or ABCC2 c.3972C>T genetic variants. Methods: Literature was searched in PubMed for eligible studies. Odds ratios (ORs) were measured using RevMan software where P-values<0.05 were statistically significant. Results: Patients inherited both UGT1A1*6 and UGT1A1*28 genetic variants (heterozygous:UGT1A1*1/*6+*1/*28 and homozygous:UGT1A1*6/*6+*28/*28) were significantly associated with increased risk of neutropenia and diarrhea compared to patients with UGT1A1*1/*1 (Neutropenia: OR 2.89; 95% CI 1.97–4.23; P<0.00001; Diarrhea: OR 2.26; 95% CI 1.71–2.99; P<0.00001). Patients carried homozygous variants had much stronger effects in developing toxicities (Neutropenia: OR 6.23; 95% CI 3.11–12.47; P<0.00001; Diarrhea: OR 3.21; 95% CI 2.13–4.85; P<0.00001) than with heterozygous variants. However, patients carried ABCC2 c.3972C>T genetic variant were not significantly associated with neutropenia (OR 1.67; 95% CI 0.98–2.84; P=0.06) but reduced diarrhea significantly (OR 0.31; 95% CI 0.11–0.81; P=0.02). Conclusions: Both UGT1A1*6 and UGT1A1*28 genetic variants should screen in Asian cancer patients to reduce substantially irinotecan-induced severe toxicities.
Jul 2022Published in Clinical and Translational Science volume 15 issue 7 on pages 1613-1633. 10.1111/cts.13277